Cost-effectiveness of continuous erythropoietin receptor activator in anemia
Holger Schmid1,21Clinic and Policlinic IV, Section of Nephrology, Munich University Hospital, Campus Innenstadt, Munich, Germany; 2KfH Nierenzentrum Muenchen Laim, Munich, GermanyBackground: Erythropoiesis-stimulating agents (ESAs) are the mainstay of anemia therapy. Continuous erythropoietin recept...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-07-01
|
| Series: | ClinicoEconomics and Outcomes Research |
| Online Access: | http://www.dovepress.com/cost-effectiveness-of-continuous-erythropoietin-receptor-activator-in--a17462 |